Get the Stockscreener App
2.23
0.45%
-0.01
After Hours:
2.24
0.01
+0.45%
Biomerica Inc stock is traded at $2.23, with a volume of 14,810.
It is down -0.45% in the last 24 hours and down -30.31% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$2.24
Open:
$2.27
24h Volume:
14,810
Relative Volume:
0.07
Market Cap:
$6.57M
Revenue:
$4.88M
Net Income/Loss:
$-3.66M
P/E Ratio:
-1.4532
EPS:
-1.5345
Net Cash Flow:
$-2.80M
1W Performance:
-7.47%
1M Performance:
-30.31%
6M Performance:
-36.47%
1Y Performance:
-13.83%
1-Day Range:
$2.23
$2.32
1-Week Range:
$2.1619
$2.44
52-Week Range:
$2.08
$10.16
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.23 | 6.60M | 4.88M | -3.66M | -2.80M | -1.5345 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
Why Biomerica Inc. stock appeals to analystsMarket Performance Recap & Breakout Confirmation Alerts - newser.com
Is Biomerica Inc. stock vulnerable to regulatory risksAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
What momentum shifts mean for Biomerica Inc.Portfolio Value Report & Safe Entry Momentum Tips - newser.com
Is Biomerica Inc. stock ready for a breakoutQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Biomerica Inc. stock trendline breakdown2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com
Can machine learning forecast Biomerica Inc. recovery2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Is it too late to sell Biomerica Inc.Earnings Miss & Technical Entry and Exit Alerts - newser.com
Will Biomerica Inc. stock remain a Wall Street favoriteIndex Update & Fast Momentum Entry Tips - newser.com
What analysts say about Biomerica Inc stockDividend Stock Watch & Small Investment Big Gains - earlytimes.in
How Biomerica Inc. stock compares to market leaders2025 Market Outlook & Low Risk High Win Rate Picks - Fundação Cultural do Pará
How Biomerica Inc. stock reacts to Fed rate cutsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
Will Biomerica Inc. stock maintain growth story2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
Biomerica expands CDMO services amid rising third-party demand By Investing.com - Investing.com Nigeria
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):